Evidence map›Paper›PMID 32234829›Full record

ArticleJournal of the American Society of Nephrology : JASN2020

Plasma Biomarkers of Tubular Injury and Inflammation Are Associated with CKD Progression in Children.

Jason H Greenberg, Alison G Abraham, Yunwen Xu, Jeffrey R Schelling, Harold I Feldman, Venkata S Sabbisetti, Mariana Cardenas Gonzalez, Steven Coca, Sarah J Schrauben, Sushrut S Waikar and 9 more

Registry-linked trialOpen access · greenAbstract readMulticenter Study
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT00327860 (Chronic Kidney Disease in Children Prospective Cohort Study), which is not on this map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT00327860 recruitingnot on this map

Chronic Kidney Disease in Children Prospective Cohort Study (CKiD)

TypeobservationalSponsorJohns Hopkins Bloomberg School of Public HealthRan2003 to 2028Enrolled1,300ConditionsChronic Kidney Disease
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 66 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Biomarker Panels for Discriminating Risk of CKD Progression in Children.Journal of the American Society of Nephrology : JASN · 2025
    Article
  7. Review
  8. Article
  9. The role of PI3K/Akt signaling pathway in chronic kidney disease.International urology and nephrology · 2024
    Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 9 institutions in 1 country.

Jason H GreenbergDepartment of Pediatrics, Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut jason.greenberg@yale.edu.ORCID 0000-0001-5874-1109
Alison G AbrahamDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Yunwen XuDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Jeffrey R SchellingDivision of Nephrology, Department of Internal Medicine, MetroHealth Campus, Case Western Reserve University School of Medicine, Cleveland, Ohio.
Harold I FeldmanDepartment of Medicine, Clinical Center for Biostatistics and Epidemiology, The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Venkata S SabbisettiDepartment of Internal Medicine, Section of Nephrology, Brigham and Women's Hospital, Boston, Massachusetts.
Mariana Cardenas GonzalezDepartment of Internal Medicine, Section of Nephrology, Brigham and Women's Hospital, Boston, Massachusetts.
Steven CocaDepartment of Internal Medicine, Section of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York.ORCID 0000-0002-0928-9168
Sarah J SchraubenDepartment of Medicine, Clinical Center for Biostatistics and Epidemiology, The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Sushrut S WaikarDepartment of Internal Medicine, Section of Nephrology, Brigham and Women's Hospital, Boston, Massachusetts.
Vasan S RamachandranDepartments of Medicine and Epidemiology, Boston University School of Medicine, Boston, Massachusetts.
Michael G ShlipakDepartment of Medicine, University of California, San Francisco, California.
Bradley WaradyDivision of Nephrology, Department of Pediatrics, Children's Mercy Kansas City, Kansas City, Missouri.
Paul L KimmelNational Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland.
Joseph V BonventreDepartment of Internal Medicine, Section of Nephrology, Brigham and Women's Hospital, Boston, Massachusetts.
Michelle DenburgDivision of Nephrology, Department of Pediatrics, The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
Chirag R ParikhDepartment of Internal Medicine, Section of Nephrology, Johns Hopkins School of Medicine, Baltimore, Maryland.ORCID 0000-0001-9051-7385
Susan FurthDivision of Nephrology, Department of Pediatrics, The Children's Hospital of Philadelphia, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
CKD Biomarkers Consortium
Brigham and Women's Hospital · USChildren's Hospital of Philadelphia · USJohns Hopkins University · USYale University · USBoston University · USChildren's Mercy Hospital · USIcahn School of Medicine at Mount Sinai · USUniversity of California, San Francisco · USUniversity School · US

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Chronic Kidney Disease in Children Study (C-Kid)U01DK066174 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI SUSAN L. FURTH · 2003 to 2026
$25.1M
CKiD Cardiovascular Testing Travel SupplementU01DK066143 · NIDDK · CHILDREN'S MERCY HOSP (KANSAS CITY, MO) · PI Bradley Alan Warady · 2003 to 2026
$24.2M
The Kidney Disease in Children Data Management and Analysis Center (KIDMAC)U01DK066116 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI MUNOZ, ALVARO · 2003 to 2017
$17.9M
Renal Physiology and Phenotyping CoreP30DK079310 · NIDDK · YALE UNIVERSITY · PI ARONSON, PETER S. · 2008 to 2022
$16.8M
The Kidney Disease in Children Data Management and Analysis Center (KIDMAC)U24DK066116 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI Derek K Ng · 2018 to 2026
$12.6M
Novel Biomarkers in Cardiac Surgery to Detect Acute Kidney InjuryR01HL085757 · NHLBI · YALE UNIVERSITY · PI PARIKH, CHIRAG R · 2007 to 2019
$10.3M
KIDNEY INJURY MOLECULE-1 IN EPITHELIAL REPAIRR01DK072381 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 2005 to 2025
$8.6M
Proteomic Approach to CKD Biomarker Discovery and ValidationU01DK085689 · NIDDK · JOHNS HOPKINS UNIVERSITY · PI CORESH, JOSEF · 2009 to 2019
$5.6M
Chronic Kidney Disease (CKD) Biomarkers Consortium Data Coordinating CenterU01DK103225 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI SCHRAUBEN, SARAH JEANNE · 2014 to 2020
$5.5M
Urinary Biomarkers of Chronic Kidney Disease Pathology and ProgressionU01DK085660 · NIDDK · BRIGHAM AND WOMEN'S HOSPITAL · PI BONVENTRE, JOSEPH VINCENT, WAIKAR, SUSHRUT S. · 2009 to 2019
$5.3M
Mechanisms of Ischemic Kidney Injury and RepairR37DK039773 · NIDDK · MASSACHUSETTS GENERAL HOSPITAL · PI BONVENTRE, JOSEPH VINCENT · 1993 to 2021
$5.2M
NCATS NIH HHS UL1 TR001863NHLBI NIH HHS R01 HL085757NIDDK NIH HHS K08 DK110536NIDDK NIH HHS K23 DK118198NIDDK NIH HHS K24 DK078737NIDDK NIH HHS K24 DK090203NIDDK NIH HHS L30 DK110819NIDDK NIH HHS L40 DK110937NIDDK NIH HHS P30 DK079310NIDDK NIH HHS R01 DK072381NIDDK NIH HHS R37 DK039773NIDDK NIH HHS U01 DK066116NIDDK NIH HHS U01 DK066143NIDDK NIH HHS U01 DK066174NIDDK NIH HHS U01 DK082185NIDDK NIH HHS U01 DK082194NIDDK NIH HHS U01 DK085660NIDDK NIH HHS U01 DK085689NIDDK NIH HHS U01 DK102730NIDDK NIH HHS U01 DK103225NIDDK NIH HHS U01 DK106982NIDDK NIH HHS U24 DK066116
6 · The paper itself

Abstract

backgroundAfter accounting for known risk factors for CKD progression in children, clinical outcomes among children with CKD still vary substantially. Biomarkers of tubular injury (such as KIM-1), repair (such as YKL-40), or inflammation (such as MCP-1, suPAR, TNF receptor-1 [TNFR-1], and TNFR-2) may identify children with CKD at risk for GFR decline.

methodsWe investigated whether plasma KIM-1, YKL-40, MCP-1, suPAR, TNFR-1, and TNFR-2 are associated with GFR decline in children with CKD and in subgroups defined by glomerular versus nonglomerular cause of CKD. We studied participants of the prospective CKiD Cohort Study which enrolled children with an eGFR of 30-90 ml/min per 1.73 m

resultsOf the 651 children evaluated (median age 11 years; median baseline eGFR of 53 ml/min per 1.73 m

conclusionsHigher plasma KIM-1, TNFR-1, and TNFR-2 are independently associated with CKD progression in children.

Indexed as

AdolescentBiomarkersChemokine CCL2ChildChitinase-3-Like Protein 1Disease ProgressionFemaleFollow-Up StudiesGlomerular Filtration RateHepatitis A Virus Cellular Receptor 1HumansInflammationKidney TubulesMaleProportional Hazards ModelsProspective StudiesBiomarkersCCL2 protein, humanChemokine CCL2CHI3L1 protein, humanChitinase-3-Like Protein 1HAVCR1 protein, humanHepatitis A Virus Cellular Receptor 1Receptors, Tumor Necrosis Factor, Type IReceptors, Tumor Necrosis Factor, Type IIReceptors, Urokinase Plasminogen ActivatorChronic inflammationchronic kidney diseasepediatric nephrologyrenal injury

Identifiers

PMID32234829
PMCPMC7217410
OpenAlexW3014106109

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.